In sum, we have shown that GIT1 is closely associated with poor prognosis in HNSCC patients and facilitates cell growth, metastasis, and EMT by upregulating PI3K/AKT/mTOR signaling pathway. The gene discussed is GIT1; the disease is head and neck squamous cell carcinoma.